Skip to main content

Table 5 Structures, predicted pIC50 of the lead compound and the designed analogues

From: Salicylic acid derivatives as potential α-glucosidase inhibitors: drug design, molecular docking and pharmacokinetic studies

S/No

Structures

Predicted pIC50

Lead compound

3.32

A1

4.32

A2

4.80

A3

4.48

A4

5.11

A5

4.50